midazolam has been researched along with Alkalosis, Respiratory in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Alkalosis, Respiratory: A state due to excess loss of carbon dioxide from the body. (Dorland, 27th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Stenkamp, K | 1 |
Palva, JM | 1 |
Uusisaari, M | 1 |
Schuchmann, S | 1 |
Schmitz, D | 1 |
Heinemann, U | 1 |
Kaila, K | 1 |
1 other study available for midazolam and Alkalosis, Respiratory
Article | Year |
---|---|
Enhanced temporal stability of cholinergic hippocampal gamma oscillations following respiratory alkalosis in vitro.
Topics: 2-Amino-5-phosphonovalerate; Alkalosis, Respiratory; Animals; Carbachol; Carbon Dioxide; Cholinergic | 2001 |